RTO vs. TRI: Which Stock Is the Better Value Option? — Neutral
RTO TRI Zacks Investment Research — November 10, 2025Investors interested in stocks from the Business - Services sector have probably already heard of Rentokil Initial PLC (RTO) and Thomson Reuters (TRI). But which of these two stocks offers value investors a better bang for their buck right now?
SOLV or DHR: Which Is the Better Value Stock Right Now? — Positive
DHR SOLV Zacks Investment Research — November 10, 2025Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
HDB or CMWAY: Which Is the Better Value Stock Right Now? — Positive
CMWAY HDB Zacks Investment Research — November 10, 2025Investors interested in Banks - Foreign stocks are likely familiar with HDFC Bank (HDB) and Commonwealth Bank of Australia Sponsored ADR (CMWAY). But which of these two companies is the best option for those looking for undervalued stocks?
Tesla's Model Y program manager announces exit alongside Cybertruck lead — Negative
TSLA Reuters — November 10, 2025Tesla's best-selling Model Y's program manager, Emmanuel Lamacchia, announced his departure on Sunday after nearly eight years, marking another high-profile exit from Elon Musk's electric vehicle company.
FOX vs. NFLX: Which Stock Is the Better Value Option? — Positive
FOX NFLX Zacks Investment Research — November 10, 2025Investors interested in Broadcast Radio and Television stocks are likely familiar with Fox Corporation (FOX) and Netflix (NFLX). But which of these two stocks is more attractive to value investors?
JBTM vs. SYM: Which Stock Is the Better Value Option? — Positive
JBTM SYM Zacks Investment Research — November 10, 2025Investors with an interest in Technology Services stocks have likely encountered both JBT Marel (JBTM) and Symbotic Inc. (SYM). But which of these two companies is the best option for those looking for undervalued stocks?
CIB vs. FSS: Which Stock Is the Better Value Option? — Positive
CIB FSS Zacks Investment Research — November 10, 2025Investors looking for stocks in the Diversified Operations sector might want to consider either Grupo Cibest (CIB) or Federal Signal (FSS). But which of these two companies is the best option for those looking for undervalued stocks?
Air Products and Chemicals (APD) Could Be a Great Choice — Positive
APD Zacks Investment Research — November 10, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?
Why Kroger (KR) is a Great Dividend Stock Right Now — Positive
KR Zacks Investment Research — November 10, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Kroger (KR) have what it takes?
Meta's Plunge Looks Tempting, But It's No Opportunity (Downgrade) — Negative
META Seeking Alpha — November 10, 2025Meta Platforms, Inc.'s 20% stock plunge reflects a rational market re-pricing rather than an emotional selloff. Despite strong Q3 growth, Meta's topline expansion is clearly decelerating due to its already saturated user base. Future growth depends heavily on monetization per user, which faces natural limits and sustainability concerns.
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRX — Neutral
MRX Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Berkshire's Buffett to Keep Class A Stock Until Investors Get Comfort With Successor — Neutral
BRK-A BRK-B WSJ — November 10, 2025Warren Buffett shares his thoughts on his career and Berkshire's future in a letter.
Wall Street is Pounding the Table Over NVDA, RUN, LLY — Neutral
LLY NVDA RUN 24/7 Wall Street — November 10, 2025In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.
Cavco Industries is upgraded to a soft "Buy" due to its resilience and growth despite broader housing market weakness. CVCO's niche in factory-built homes, recent acquisition of American Homestar, and strong backlog support continued expansion. The company boasts a fortress balance sheet with no debt and significant cash reserves, enhancing its financial stability.
From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside — Positive
QURE Seeking Alpha — November 10, 2025UniQure stock is rated a Buy with a $66 price target, offering upside after recent FDA pushback on AMT-130 Huntington's therapy trial design. AMT-130 is the first disease-modifying therapy for Huntington's, showing 75% slowing of disease progression and significant functional benefit in Phase 1/2 data. Modeling suggests a 78% probability of eventual approval (accelerated or post-Phase 3), with near-term catalysts including FDA meeting minutes and EMA discussions.
Papa John's stock higher on go-private report — Positive
PZZA Proactive Investors — November 10, 2025Papa John's International Inc (NASDAQ:PZZA) shares gained 5% to $43.05 on Monday following a report that the pizza maker is in advanced discussions with TriArtisan Capital to be taken private at $65 per share, according to ABC Money UK, which cited people familiar with the talks. The potential acquisition price would value Papa John's at $2.7 billion.
An Earnings Win With a Stock Slump: What's Happening With D-Wave? — Neutral
QBTS MarketBeat — November 10, 2025One of the most-hyped earnings reports of the quantum industry this season ended not with a rally, but a retreat. Shares of D-Wave Quantum Inc. NYSE: QBTS fell by nearly 22% in the first full week of trading in November 2025, closing the week under $30 per share.
Bakkt Holdings, Inc. (BKKT) Q3 2025 Earnings Call Transcript — Neutral
BKKT Seeking Alpha — November 10, 2025Bakkt Holdings, Inc. ( BKKT ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Cody Fletcher Akshay Naheta - CEO & Director Karen Alexander - CFO & Principal Financial Officer Conference Call Participants Chris Brendler Mark Palmer - The Benchmark Company, LLC, Research Division Justin Pan Presentation Operator Greetings, and welcome to the Bakkt's Third Quarter 2025 Earnings Conference Call. [Operator Instructions].
Lithium Argentina AG (LAR:CA) Q3 2025 Earnings Call Transcript — Neutral
LAR Seeking Alpha — November 10, 2025Lithium Argentina AG ( LAR:CA ) Q3 2025 Earnings Call November 10, 2025 8:00 AM EST Company Participants Kelly O'Brien - VP of Investor Relations & ESG Sam Pigott - CEO, President & Director Xiaoshen Wang - President & Vice Chairman Jason Luo Carlos Galli - Chief Operating Officer Conference Call Participants Joel Jackson - BMO Capital Markets Equity Research Katie Lachapelle - Canaccord Genuity Corp., Research Division Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Corinne Blanchard - Deutsche Bank AG, Research Division David Deckelbaum - TD Cowen, Research Division Mohamed Sidibe - National Bank Financial, Inc., …
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at UBS Global Healthcare Conference 2025 Transcript — Neutral
ALNY Seeking Alpha — November 10, 2025Alnylam Pharmaceuticals, Inc. ( ALNY ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Jeffrey Poulton - CFO & Executive VP John Vest - Senior Vice President of Clinical Research Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division All right. Good day, everybody.